Living with the everyday strain of a difficult health condition or disease can be overwhelming but there is hope. Many are still unaware that there is relief from symptoms and improvement in function through adult stem cell therapies. Stem cell therapy is currently helping hundreds of patients each year with remarkable results. Though this technology is still limited in the United States, it is being used as tool to fight various conditions and illnesses around the world, including Alzheimer’s.
At BridgeHealth, we represent several elite providers so we can remain objective and focused on the best solution for you. If you are interested in learning more or finding out if you are a candidate, please contact us toll free at 1-800-680-1366 (from the US or Canada), +1-303-457-5734 or email us firstname.lastname@example.org.
Please understand as we do, that even though these treatments are making dramatic headway in previously untreatable illnesses, they are not a miracle cure. There are many factors that need to be taken into consideration to help predict how successful therapy will be. Please contact us if you are interested in learning more about how adult stem cells might help you.
"OPKO Health Announces Development of Blood Test for Alzheimer’s Disease February 11, 2010 10:47 AM Eastern Time MIAMI--(EON: Enhanced Online News)--OPKO Health, Inc. (NYSE Amex:OPK) today announced the development of a simple diagnostic blood test for Alzheimer’s disease. The test, designed to detect elevated levels of antibodies unique to Alzheimer’s disease, was approximately 95% accurate in initial testing. "
"The human prion is resistant to both heat and chemicals and is reported to be up to a hundred thousand times more difficult to deactivate than the animal form of infective agent which causes well known diseases in cattle, such as mad cow disease, and scrapie in sheep."
Any error in identifying a CJD-carrier can be fatal and costly - many hospitals around the world have been forced to destroy millions of dollars worth of instruments when patients were diagnosed with CJD some time after undergoing routine eye and neurosurgical procedures.
A further factor limiting decontamination from prions is that existing cleaning protocols are damaging to medical instruments such as flexible endoscopes and some instruments used in neurosurgical, dental and opthalmological procedures."
There are 5.3 million AD victims in the United States, with a new case every 70 seconds - an epidemic of almost a half million new cases of a transmissible prion disease each year. The CDC and medical community must promptly deal with the issue of potential iatrogenic transmission of Alzheimer's Disease.